As the clock strikes 12:01 am on Sunday morning, 2016 will abruptly and mercifully be put down like a rabid beast. While the mountain of marijuana-related research continued to grow ever higher during 2016, proving marijuana’s cannabinoids are truly medicinal; many fear our community’s hard-fought progress is potentially under threat of being rolled back by the new administration. Supportive of MMJ himself (“I think medical should happen”), Trump’s cabinet choices have been questionable with regards to what could happen in the future. With that in mind, below are ten intriguing studies conducted during 2016 that underscore his welcome endorsement.
Top 10 Studies for 2016
“Research suggests that people may be using cannabis as an exit drug to reduce use of substances that are potentially more harmful, such as opioid pain medication.”
Alarming some naysayers, scientists concluded those daily marijuana consumers with an XY chromosome (male) have a BMI that is approximately 2.7% lower than non-smokers, while daily female users (XX chromosome) have a body mass index that is approximately 3.1% lower than non-users.
Published online by the United States National Institute of Health, a group of Chinese scientist found that cannabinoids can inhibit the growth of carcinoma cancer cells. Similar to Dr. Christina Sanchez’s 2014 discovery that THC kills cancer cells, this 2016 study demonstrates that certain cannabinoids trigger specific cancer cells to parish.
A new study finds that tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are effectual at mitigating symptoms of dementia. The report, published in the U.S. National Library of Medicine – National Institutes of Health, shows that marijuana’s two primary cannabinoids provide hope and help for those suffering from dementia.
Thanks to the never-ending tenacity of individuals like Dr. Sue Sisley, the FDA has finally provided its long-overdue approval for testing marijuana’s miracle compounds as a potential treatment for veterans returning home from combat with PTSD (post-traumatic stress disorder).
In the first experiment of its kind, Dr. Adi Eran, head of the Pediatric Neurology Department at Shaare Zedek Medical Center in Jerusalem, is planning to test 120 low- to medium-functioning autistic individuals from ages 4 to 30 years. Researchers will administer cannabis oils that are rich in CBD but do not contain enough THC to produce any psychoactive effect.
Tapping the keg of America’s never-ending violence, “intoxicated aggression” spikes precipitously among drinkers, while marijuana snuffs out those same aggressive tendencies. At least that’s the takeaway message from a peer-reviewed study just published in the July 2016 edition of Springer Science.
Increasing productivity and profitability from coast-to-coast, a new study indicates employees in states with medical marijuana laws enjoy a reduced rate of absenteeism, due to illness.
Offering help and hope to those suffering from intractable pediatric epilepsy, a January 6, 2016 study published on PubMed.gov demonstrated children suffering from seizures have benefited greatly from the administration of a high-CBD cannabis oil.
By simply smoking pot, humans inadvertently activate their CB2 receptor. Once activated, research indicates the cannabinoid 2 (CB2) receptor plays a key regulatory role on the secretion of insulin, immune modulation and insulin resistance.
A historic and groundbreaking year, 2016 ushered in a new era for the marijuana reform movement. During the 2016 election cycle, eight states legalized recreational marijuana consumption and several more legalized medicinal cannabis. Putting presidential politics aside, our country made some incredible progress this year. Thanks to the voters in California, Nevada, Massachusetts, and Maine, our freedom loving country has inched ever closer to permanently snuffing out the costly prohibition of a peaceful plant, while the majority of the U.S. has thoroughly embraced the efficacy of medical cannabis.
Happy New Year 420-world, Peace!